ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Osteomyelitis associated with open fractures in adults

Osteomyelitis associated with open fractures in adults
Literature review current through: Jan 2024.
This topic last updated: Nov 30, 2023.

INTRODUCTION — Osteomyelitis may develop as a result of contamination of open fractures [1-3].

The epidemiology, microbiology, clinical manifestations, treatment, and prevention of osteomyelitis in the setting of open fractures will be reviewed here.

General principles of fracture management are discussed separately. (See "General principles of fracture management: Early and late complications", section on 'Open fractures' and "General principles of fracture management: Early and late complications", section on 'Osteomyelitis'.)

General issues related to osteomyelitis are discussed separately. (See "Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis" and "Nonvertebral osteomyelitis in adults: Treatment".)

Issues related to prosthetic joint infections are discussed separately. (See "Prosthetic joint infection: Epidemiology, microbiology, clinical manifestations, and diagnosis" and "Prosthetic joint infection: Treatment".)

Issues related to infection following nail puncture are discussed separately. (See "Pseudomonas aeruginosa skin and soft tissue infections", section on 'Infection following nail puncture'.)

Issues related to injury associated with bites are discussed separately. (See "Animal bites (dogs, cats, and other mammals): Evaluation and management" and "Human bites: Evaluation and management".)

Issues related to injury associated with water are discussed separately. (See "Soft tissue infections following water exposure".)

EPIDEMIOLOGY — Osteomyelitis can occur in up to 25 percent of open fractures; the risk depends upon the following factors [4-10]:

Severity of injury, including whether concurrent vascular and/or neurologic damage is present

Degree of bacterial contamination

Timing and adequacy of surgical debridement

Administration of antibiotics (including the timing as well as the type)

Diabetes mellitus

Comminuted fracture

Surgical incision >10 cm [11]

In one review including more than 1100 open fracture wounds, the risk of infection with open tibia fracture was twice as high as for open fracture of other sites (10.5 versus 5.3 percent) [7]. The infection rate after open hand fracture is relatively low; in one review including twelve articles (4 prospective, 8 retrospective) and 1669 open fractures of the hand, the infection rate was approximately 3 to 4 percent [12].

Infection results in a 1.2 to 6-fold increase in costs associated with fracture [13].

MICROBIOLOGY — Microorganisms can be introduced directly into bone in the setting of fracture or via contiguous spread from injury to overlying soft tissue. They proliferate in the presence of devitalized tissues containing clotted blood and necrotic bone.

Pathogens may include skin flora, environmental organisms, or nosocomial pathogens. The most common organisms include Staphylococcus aureus, coagulase-negative staphylococci, and aerobic gram-negative bacilli. Other less commonly implicated pathogens include enterococci, anaerobes, fungi, and mycobacteria [6,14-20]. If the fracture is associated with water, infection may be caused by Pseudomonas, Aeromonas, or Vibrio species (see "Soft tissue infections following water exposure"). Infections are polymicrobial in 25 to 35 percent of cases [21,22].

The microbiologic diagnosis is established via cultures obtained at the time of debridement for possible infection, rather than at the time of initial debridement following fracture. Cultures obtained at the time of initial debridement correlate with established pathogens of osteomyelitis in only 25 percent of cases [23,24]. Not all microbes colonizing the wound at the time of injury cause sustained infection in the bone, and pathogens not present at the initial injury may colonize and infect wounds subsequently.

CLINICAL MANIFESTATIONS — The approach to classification of open fractures is summarized in the table (table 1).

Acute osteomyelitis following fracture usually presents with gradual progression of dull localized pain over several days. Local findings (tenderness, warmth, erythema, swelling) and systemic symptoms (fever, rigors) may be present. Decreased range of motion, point tenderness, and joint effusions may be seen but are also present with uninfected fractures, making clinical diagnosis potentially difficult.

In some cases, osteomyelitis presents with few symptoms or signs. This is more common with subacute or chronic infections, with infections of the hip, pelvis, or vertebrae, and in young patients.

Chronic osteomyelitis may present with pain, erythema, or swelling, sometimes in association with a draining sinus tract. Fractures that are healing slower than expected or that remain extremely painful despite adequate immobilization may be a sign that osteomyelitis is present.

After open fracture, non-union is the most common consequence and manifestation of osteomyelitis. Non-unions commonly present with persistent pain, swelling, or instability beyond the time when healing should normally have occurred. Nonunion is not always due to infection; other causes include lack of adequate blood supply, suboptimal bone alignment, and smoking.

Additional manifestations of osteomyelitis and non-union associated with fracture are discussed separately. (See "General principles of fracture management: Early and late complications", section on 'Osteomyelitis' and "General principles of fracture management: Early and late complications", section on 'Nonunion and malunion'.)

DIAGNOSIS — The approach to diagnosis of osteomyelitis following open fracture is the same as the approach to diagnosis of osteomyelitis due to other causes; this is discussed separately. (See "Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis" and "Approach to imaging modalities in the setting of suspected nonvertebral osteomyelitis".)

TREATMENT — Following a fracture, initial management of osteomyelitis or infected non-union consists of surgical debridement with irrigation, obtaining bone biopsy for culture, fracture fixation (if needed), and antimicrobial therapy tailored to culture and susceptibility data [17,25-35].

To achieve optimal union in the setting of concomitant osteomyelitis, it may be necessary to administer systemic antibiotic therapy for as long as fixation hardware remains in place. Once fracture union is achieved, fixation hardware should be removed (if possible), with additional debridement.

Antibiotic-impregnated beads may be used as adjunctive therapy in surgical management of trauma-associated osteomyelitis [36].

The approach to antibiotic therapy for patients with retained hardware is discussed separately. (See "Nonvertebral osteomyelitis in adults: Treatment", section on 'Retained hardware'.)

The approach to antibiotic therapy for patients with no retained hardware is discussed separately. (See "Nonvertebral osteomyelitis in adults: Treatment", section on 'No retained hardware'.)

Antibiotic selection and other issues related to treatment of osteomyelitis are discussed in detail separately. (See "Nonvertebral osteomyelitis in adults: Treatment", section on 'Antibiotic therapy'.)

PREVENTION — Measures for prevention of osteomyelitis following open fracture include prompt debridement, surgical fixation (if needed), and antibiotic therapy [1].

Initial fracture management — General principles of acute fracture management are discussed separately. (See "General principles of acute fracture management" and "General principles of fracture management: Early and late complications", section on 'Open fractures'.)

In general, initial fracture management consists of thorough irrigation and debridement. The optimal timing of debridement is uncertain; some have suggested that open fractures should be debrided within six hours of injury [37-39]. In one meta-analysis of observational and trial data, the risk of infection for tibial fractures was higher when debridement took place after 12 hours; for Gustilo type III-B fractures (table 1), risk of infection rose after 12 hours (odds ratio [OR] 1.51) and 24 hours (OR 2.17) [40].

The decision regarding use of fixation hardware for stabilization is made on a case-by-case basis.

At the time of initial debridement, there is no need for operative routine cultures. If subsequent debridement is performed for suspected infection, collection of operative cultures is warranted at that time. (See 'Microbiology' above.)

Once union is achieved, fixation hardware may be removed and additional debridement performed if needed. Final steps include bone grafting (if needed) and wound closure [26-35,41].

Primary closure may be reasonable for debrided wounds with no contamination, good residual soft tissue, and good vascular supply [42]. Delayed wound closure is generally warranted in Gustilo type II or III fractures (table 1).

Antibiotics after open fracture — The use of antimicrobial agents for dirty procedures or established infection is classified as treatment of presumed infection, rather than prophylaxis. (See "Antimicrobial prophylaxis for prevention of surgical site infection in adults", section on 'Wound classification'.)

Following open fracture, prompt administration of antibiotics (ideally within six hours) is warranted to reduce the risk of osteomyelitis [2,3,43-45]. This approach is supported by a meta-analysis including 913 patients with open fractures [41]; use of antibiotics was associated with an absolute reduction in infection of 0.08 (95% CI 0.04-0.12) [41].

Antibiotic selection — Antibiotic regimens for patients with open fractures are summarized in the table (table 2).

For patients with type I and type II fractures (table 1), antibiotic therapy should include activity against gram-positive organisms. Cefazolin is a reasonable regimen; for patients at risk for methicillin-resistant S. aureus (table 3), gram-positive coverage should consist of vancomycin (table 4). Dosing is summarized in the table (table 2).

For patients with type III fractures (table 1), antibiotic therapy should include activity against gram-negative organisms (in addition to gram-positive coverage outlined above) [2,46]. For example, ceftriaxone (monotherapy) is an acceptable regimen [2,47]. Dosing is summarized in the table (table 2).

For patients with open fracture associated with soil contamination, we favor addition of metronidazole to the above regimens, for coverage of Clostridium spp.

For patients with open fracture associated with freshwater contamination, we favor piperacillin-tazobactam for activity against gram-negative pathogens such as Pseudomonas and Aeromonas species.

For patients with open fracture associated with seawater contamination, we favor levofloxacin plus metronidazole for activity against Vibrio species. Dosing is summarized in the table (table 2).

Data to guide the above approach to antibiotic selection are limited, and the optimal approach is uncertain. Our approach is guided by the typical microbiology of such infections as well as general trends in antimicrobial resistance.

Duration — The duration of antibiotic therapy depends on the classification of the fracture (table 1) [2,3,48,49]:

For Gustilo type I and II open fractures, antibiotics may be discontinued 24 hours after wound closure.

For Gustilo type III open fractures, antibiotics may be discontinued after 72 hours or within a day after soft tissue injuries have been closed.

Prolonged administration of antibiotics does not reduce the risk of infection and can lead to the development of resistant organisms [3,50].

Tetanus prophylaxis — Open fractures are tetanus-prone wounds [51,52]. The patient's tetanus immunization status should be determined; tetanus toxoid, diphtheria-tetanus-acellular pertussis, booster tetanus toxoid-reduced diphtheria toxoid-acellular pertussis, or tetanus-diphtheria toxoids adsorbed should be administered as indicated (table 5). The need for tetanus immune globulin should also be assessed (table 5). (See "Tetanus".)

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Osteomyelitis and prosthetic joint infection in adults".)

SUMMARY AND RECOMMENDATIONS

Pathogenesis and microbiology – Osteomyelitis may develop as a result of contamination of open fractures in up to 25 percent of cases. Microorganisms can be introduced directly into bone in the setting of open fractures or via contiguous spread from injury to overlying soft tissue. Pathogens may include skin flora, environmental organisms, or nosocomial pathogens. (See 'Epidemiology' above and 'Microbiology' above.)

Clinical approach – The approach to classification of open fractures is summarized in the table (table 1). The approach to diagnosis of osteomyelitis following open fracture is the same as the approach to diagnosis of osteomyelitis due to other causes; this is discussed separately. (See 'Clinical manifestations' above and "Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis".)

Management – Following a fracture, initial management of osteomyelitis or infected non-union consists of surgical debridement with irrigation, obtaining bone biopsy for culture, fracture fixation (if needed), and antimicrobial therapy tailored to culture and susceptibility data. To achieve optimal union, it may be necessary to administer systemic antibiotic therapy for as long as fixation hardware remains in place. Once fracture union is achieved, fixation hardware should be removed (if possible), with additional debridement if needed. (See 'Treatment' above.)

Prevention of osteomyelitis – Measures for prevention of osteomyelitis following open fracture include prompt debridement, surgical fixation (if needed), antibiotic therapy, and assessment regarding need for tetanus prophylaxis. (See 'Prevention' above.)

Antibiotic selection – Following open fracture, prompt administration of antibiotics (ideally within six hours) is warranted to reduce the risk of osteomyelitis (table 2). For patients with type I and type II fractures, antibiotic therapy should include activity against gram-positive organisms. For patients with type III fractures, antibiotic therapy should include activity against gram-positive and gram-negative organisms. The duration of antibiotic therapy depends on the classification of the fracture. (See 'Antibiotics after open fracture' above.)

  1. Schmitt SK. Osteomyelitis. Infect Dis Clin North Am 2017; 31:325.
  2. Hoff WS, Bonadies JA, Cachecho R, Dorlac WC. East Practice Management Guidelines Work Group: update to practice management guidelines for prophylactic antibiotic use in open fractures. J Trauma 2011; 70:751.
  3. Pasquale M, Fabian TC. Practice management guidelines for trauma from the Eastern Association for the Surgery of Trauma. J Trauma 1998; 44:941.
  4. Merritt K. Factors increasing the risk of infection in patients with open fractures. J Trauma 1988; 28:823.
  5. DeLong WG Jr, Born CT, Wei SY, et al. Aggressive treatment of 119 open fracture wounds. J Trauma 1999; 46:1049.
  6. Gross T, Kaim AH, Regazzoni P, Widmer AF. Current concepts in posttraumatic osteomyelitis: a diagnostic challenge with new imaging options. J Trauma 2002; 52:1210.
  7. Patzakis MJ, Wilkins J. Factors influencing infection rate in open fracture wounds. Clin Orthop Relat Res 1989; :36.
  8. Tsukayama DT. Pathophysiology of posttraumatic osteomyelitis. Clin Orthop Relat Res 1999; :22.
  9. Lavery LA, Walker SC, Harkless LB, Felder-Johnson K. Infected puncture wounds in diabetic and nondiabetic adults. Diabetes Care 1995; 18:1588.
  10. Court-Brown CM, Rimmer S, Prakash U, McQueen MM. The epidemiology of open long bone fractures. Injury 1998; 29:529.
  11. Slyamova G, Gusmanov A, Batpenov A, et al. Risk Factors for Postoperative Osteomyelitis among Patients after Bone Fracture: A Matched Case-Control Study. J Clin Med 2022; 11.
  12. Ketonis C, Dwyer J, Ilyas AM. Timing of Debridement and Infection Rates in Open Fractures of the Hand: A Systematic Review. Hand (N Y) 2017; 12:119.
  13. O'Connor O, Thahir A, Krkovic M. How Much Does an Infected Fracture Cost? Arch Bone Jt Surg 2022; 10:135.
  14. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004; 364:369.
  15. Khatod M, Botte MJ, Hoyt DB, et al. Outcomes in open tibia fractures: relationship between delay in treatment and infection. J Trauma 2003; 55:949.
  16. Mader JT, Ortiz M, Calhoun JH. Update on the diagnosis and management of osteomyelitis. Clin Podiatr Med Surg 1996; 13:701.
  17. Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury 2006; 37 Suppl 2:S59.
  18. Haas DW, McAndrew MP. Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am J Med 1996; 101:550.
  19. Karam GH, Ackley AM, Dismukes WE. Posttraumatic Aeromonas hydrophila osteomyelitis. Arch Intern Med 1983; 143:2073.
  20. Lavery LA, Harkless LB, Felder-Johnson K, Mundine S. Bacterial pathogens in infected puncture wounds in adults with diabetes. J Foot Ankle Surg 1994; 33:91.
  21. Lu V, Zhang J, Patel R, et al. Fracture Related Infections and Their Risk Factors for Treatment Failure-A Major Trauma Centre Perspective. Diagnostics (Basel) 2022; 12.
  22. Depypere M, Sliepen J, Onsea J, et al. The Microbiological Etiology of Fracture-Related Infection. Front Cell Infect Microbiol 2022; 12:934485.
  23. Kindsfater K, Jonassen EA. Osteomyelitis in grade II and III open tibia fractures with late debridement. J Orthop Trauma 1995; 9:121.
  24. Lee J. Efficacy of cultures in the management of open fractures. Clin Orthop Relat Res 1997; :71.
  25. Roesgen M, Hierholzer G, Hax PM. Post-traumatic osteomyelitis. Pathophysiology and management. Arch Orthop Trauma Surg 1989; 108:1.
  26. Cierny G, Mader JT. Adult chronic osteomyelitis. Orthopedics 1984; 7:1557.
  27. Böhm E, Josten C. What's new in exogenous osteomyelitis? Pathol Res Pract 1992; 188:254.
  28. Meadows SE, Zuckerman JD, Koval KJ. Posttraumatic tibial osteomyelitis: diagnosis, classification, and treatment. Bull Hosp Jt Dis 1993; 52:11.
  29. Anthony JP, Mathes SJ, Alpert BS. The muscle flap in the treatment of chronic lower extremity osteomyelitis: results in patients over 5 years after treatment. Plast Reconstr Surg 1991; 88:311.
  30. May JW Jr, Jupiter JB, Gallico GG 3rd, et al. Treatment of chronic traumatic bone wounds. Microvascular free tissue transfer: a 13-year experience in 96 patients. Ann Surg 1991; 214:241.
  31. Culliford AT 4th, Spector J, Blank A, et al. The fate of lower extremities with failed free flaps: a single institution's experience over 25 years. Ann Plast Surg 2007; 59:18.
  32. Clifford RP, Beauchamp CG, Kellam JF, et al. Plate fixation of open fractures of the tibia. J Bone Joint Surg Br 1988; 70:644.
  33. Clifford RP, Lyons TJ, Webb JK. Complications of external fixation of open fractures of the tibia. Injury 1987; 18:174.
  34. Chapman MW. The role of intramedullary fixation in open fractures. Clin Orthop Relat Res 1986; :26.
  35. Etter C, Burri C, Claes L, et al. Treatment by external fixation of open fractures associated with severe soft tissue damage of the leg. Biomechanical principles and clinical experience. Clin Orthop Relat Res 1983; :80.
  36. Thahir A, Lim JA, West C, Krkovic M. The Use of Calcium Sulphate Beads in the Management of Osteomyelitis of Femur and Tibia: A Systematic Review. Arch Bone Jt Surg 2022; 10:320.
  37. Prodromidis AD, Charalambous CP. The 6-Hour Rule for Surgical Debridement of Open Tibial Fractures: A Systematic Review and Meta-Analysis of Infection and Nonunion Rates. J Orthop Trauma 2016; 30:397.
  38. Schenker ML, Yannascoli S, Baldwin KD, et al. Does timing to operative debridement affect infectious complications in open long-bone fractures? A systematic review. J Bone Joint Surg Am 2012; 94:1057.
  39. Calhoun JH. Optimal timing of operative debridement: a known unknown: commentary on an article by Mara L. Schenker, MD, et al.: “Does timing to operative debridement affect infectious complications in open long-bone fractures? A systematic review”. J Bone Joint Surg Am 2012; 94:e90.
  40. Foote CJ, Tornetta P 3rd, Reito A, et al. A Reevaluation of the Risk of Infection Based on Time to Debridement in Open Fractures: Results of the GOLIATH Meta-Analysis of Observational Studies and Limited Trial Data. J Bone Joint Surg Am 2021; 103:265.
  41. Gosselin RA, Roberts I, Gillespie WJ. Antibiotics for preventing infection in open limb fractures. Cochrane Database Syst Rev 2004; :CD003764.
  42. Rajasekaran S. Early versus delayed closure of open fractures. Injury 2007; 38:890.
  43. Patzakis MJ, Wilkins J, Moore TM. Considerations in reducing the infection rate in open tibial fractures. Clin Orthop Relat Res 1983; :36.
  44. Seligson D, Henry SL. Treatment of compound fractures. Am J Surg 1991; 161:693.
  45. Patzakis MJ, Bains RS, Lee J, et al. Prospective, randomized, double-blind study comparing single-agent antibiotic therapy, ciprofloxacin, to combination antibiotic therapy in open fracture wounds. J Orthop Trauma 2000; 14:529.
  46. Vasenius J, Tulikoura I, Vainionpää S, Rokkanen P. Clindamycin versus cloxacillin in the treatment of 240 open fractures. A randomized prospective study. Ann Chir Gynaecol 1998; 87:224.
  47. Rodriguez L, Jung HS, Goulet JA, et al. Evidence-based protocol for prophylactic antibiotics in open fractures: improved antibiotic stewardship with no increase in infection rates. J Trauma Acute Care Surg 2014; 77:400.
  48. Hauser CJ, Adams CA Jr, Eachempati SR, Council of the Surgical Infection Society. Surgical Infection Society guideline: prophylactic antibiotic use in open fractures: an evidence-based guideline. Surg Infect (Larchmt) 2006; 7:379.
  49. Gillespie WJ, Walenkamp GH. Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database Syst Rev 2010; :CD000244.
  50. Dellinger EP, Caplan ES, Weaver LD, et al. Duration of preventive antibiotic administration for open extremity fractures. Arch Surg 1988; 123:333.
  51. Talan DA, Citron DM, Abrahamian FM, et al. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med 1999; 340:85.
  52. Muguti GI, Dixon MS. Tetanus following human bite. Br J Plast Surg 1992; 45:614.
Topic 7659 Version 24.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟